Desloratadine是一种有效的人组胺H1受体拮抗剂,IC50为51nM.
Desloratadine is a potent antagonist for human histamine H1 receptor with IC50 of 51 nM.
10mg/kg皮下注射
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Yoko Nagaya et. Al. Drug Metabolism and Pharmacokinetics, 29(5), 419-426 (2014).
[2] Shigeru Hishinuma et. Al. Biochemical Pharmacology, 91(2), 231-241 (2014).
分子式 C19H19ClN2 |
分子量 310.82 |
CAS号 100643-71-8 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 26 mg/mL |
Water <1 mg/mL |
Ethanol 60 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00817076 | Dermatitis, Atopic | Drug: desloratadine | Merck Sharp & Dohme Corp. | Phase 3 | 2003-03-01 | 2015-04-20 |
NCT01314352 | Fed | Drug: Desloratadine | Dr. Reddy's Laboratories Limited | Phase 1 | 2005-12-01 | 2011-06-07 |
NCT01314339 | Fasting | Drug: Desloratadine | Dr. Reddy's Laboratories Limited | Phase 1 | 2005-12-01 | 2012-02-17 |
NCT00536380 | Chronic Idiopathic Urticaria | Drug: 5-mg Desloratadine|Drug: 10-mg Desloratadine|Drug: 20-mg Desloratadine | Merck Sharp & Dohme Corp. | Phase 4 | 2007-09-01 | 2015-10-15 |
NCT01506037 | Healthy | Drug: Desloratadine | Dr. Reddy's Laboratories Limited | Phase 1 | 2006-01-01 | 2012-01-10 |
NCT01506050 | Healthy | Drug: Desloratadine | Dr. Reddy's Laboratories Limited | Phase 1 | 2006-01-01 | 2012-01-06 |
NCT00805324 | Rhinitis, Allergic, Seasonal|Asthma | Drug: Desloratadine | Merck Sharp & Dohme Corp. | Phase 3 | 2003-05-01 | 2015-04-20 |
NCT00867191 | Seasonal Allergic Rhinitis | Drug: Placebo|Drug: Desloratadine | Merck Sharp & Dohme Corp. | Phase 4 | 2002-02-01 | 2017-03-21 |
NCT00779116 | Allergies | Drug: Desloratadine|Drug: Zyrtec(cetirizine) | Merck Sharp & Dohme Corp. | Phase 4 | 2005-09-01 | 2015-04-06 |
NCT01506791 | Healthy | Drug: Desloratadine and pseudoephedrine | Dr. Reddy's Laboratories Limited | Phase 1 | 2006-04-01 | 2012-01-05 |
NCT01373138 | Healthy | Drug: Desloratadine and pseudoephedrine | Dr. Reddy's Laboratories Limited | Phase 1 | 2006-04-01 | 2011-06-13 |
NCT00724698 | Rhinitis|Urticaria | Drug: Desloratadine | Merck Sharp & Dohme Corp. | 2005-10-01 | 2016-01-22 | |
NCT00757562 | Chronic Idiopathic Urticaria|Atopy | Drug: desloratadine|Drug: Placebo | Merck Sharp & Dohme Corp. | Phase 3 | 2002-11-01 | 2017-03-21 |
NCT00761527 | Rhinitis, Allergic, Seasonal|Rhinitis, Allergic, Perennial|Urticaria | Drug: Desloratadine Syrup | Merck Sharp & Dohme Corp. | 2008-03-01 | 2015-07-15 | |
NCT00789152 | Allergic Rhinitis | Drug: desloratadine|Drug: levocetirizine | Merck Sharp & Dohme Corp. | Phase 3 | 2003-12-01 | 2017-03-22 |
NCT00794794 | Allergic Rhinitis | Drug: Desloratadine (Clarinex)|Drug: Cetirizine (Zyrtec) | Merck Sharp & Dohme Corp. | Phase 3 | 2004-11-01 | 2015-09-21 |
NCT00794378 | Allergic Rhinitis | Drug: Desloratadine (Clarinex)|Drug: Cetirizine (Zyrtec) | Merck Sharp & Dohme Corp. | Phase 3 | 2004-11-01 | 2015-07-03 |
NCT02646020 | Non-small Cell Lung Cancer | Drug: Aprepitant and placebo|Drug: desloratadine and placebo | Sun Yat-sen University | Phase 2 | 2015-12-01 | 2016-01-02 |
NCT00779636 | Allergic Airway Disease | Drug: Desloratadine|Drug: Placebo | Merck Sharp & Dohme Corp. | Phase 4 | 2003-07-01 | 2017-03-21 |
NCT00795158 | Urticaria | Drug: desloratadine | Merck Sharp & Dohme Corp. | Phase 3 | 2002-11-01 | 2015-05-04 |
NCT00780403 | Allergies | Drug: Desloratadine|Drug: Zyrtec(cetirizine) | Merck Sharp & Dohme Corp. | Phase 4 | 2005-08-01 | 2015-09-21 |
NCT00405964 | Allergic Rhinitis | Drug: 5-mg Desloratadine|Drug: Placebo tablet | Merck Sharp & Dohme Corp. | Phase 3 | 2006-09-01 | 2015-04-09 |
NCT00406783 | Rhinitis, Allergic, Seasonal|Rhinitis, Allergic, Perennial | Drug: 5-mg Desloratadine|Drug: Placebo | Merck Sharp & Dohme Corp. | Phase 3 | 2006-08-01 | 2015-05-15 |
NCT00805584 | Rhinitis, Allergic, Seasonal | Drug: desloratadine | Merck Sharp & Dohme Corp. | Phase 4 | 2003-05-01 | 2015-04-20 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们